21 May 2019 : Clinical Research
Non-Medical Use of Prescription Stimulants for Treatment of Attention Disorders by University Students: Characteristics and Associations
Liat Korn1ABCDEF*, Kineret Hassan1CDEF, Nadya Fainshtein1CDEF, Nizmit Yusov1CDEF, Nitza Davidovitch2ACDEFGDOI: 10.12659/MSM.913973
Med Sci Monit 2019; 25:3778-3787
Abstract
BACKGROUND: Non-medical use of prescription stimulants (NPS) for treatment of attention deficit hyperactivity disorders (ADHD), which are considered narcotic substances and medical drugs, are used to treat learning and attention disorders. The purpose of this study was to investigate associations between misuse of medications for treatment of ADHD and various characteristics and problem behaviors, such as impulsivity, deviant behavior, and drug use.
MATERIAL AND METHODS: A total of 1280 undergraduate students (64% females; mean age 27; SD=6) completed an anonymous, structured, self-report questionnaire on health, well-being, and health risk behaviors.
RESULTS: NPS for treatment of ADHD was significantly associated with cannabis AOR (adjusted odds ratio)=5.57, P<0.001, compared to non-users. Deviant behaviors were significantly more prevalent among students engaging in medical use of prescription stimulants for treatment of ADHD (P=0.01; 43.2% and misuse 51.1%) versus non-users (34.5%).
CONCLUSIONS: Social attention in needed and implementing of social policy to raise students’ awareness of the problems involved in misuse of medications for treatment of ADHD, to form intervention programs tailored for students, and to refer students for appropriate counseling and diagnosis.
Keywords: Attention Deficit and Disruptive Behavior Disorders, Cannabis, Prescription Drug Misuse, Risk-Taking, Students, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Cognition Disorders, Impulsive Behavior, Israel, Marijuana Smoking, Methylphenidate, Prevalence, Substance-Related Disorders, Universities, young adult
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952